PolarityTE Inc.

PolarityTE — Investor Presentation (September 2017)

36 slides from PolarityTE's investor presentation, Sep 14, 2017

  1. Slide 1: q

    q

  2. Slide 2: Forward Looking Statements

    FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements and projections. The company makes no express or implied representation or warrant as to the completeness of this information or, in the case of projections, as to their attainability or the accuracy and completeness of

  3. Slide 3: Name one company or product that truly regenerates anything?

    ~~ \<@@ Ask yourself—Name one company or product that » 2a truly regenerates ANYTHING? (seep : #

  4. Slide 4: Without Tissue Polarity—Structure & Function is Lost

    Without Tissue Polarity—Structure & Function is Lost polarity: the tendency of living organisms or parts to ys evelop with distinct anterior and posterior (or uppermost Eo lowermost) ends, or to grow or orient in a particular irection.

  5. Slide 5: PolarityTE Company Overview

    PolarityTE™ Company Overview Oe PLATFORM OPPORTUNITY Clinical stage regenerative medicine company with a new and expanding platform technology to create functionally- polarized tissues, beginning with regenerated skin that grows all layers, glands, and hair f NN ee ee eee “TECHNOLOGICAL ADVANTAGE Au

  6. Slide 6: The PolarityTEAM — Management

    DenverLough, MD, PhD Chief Executive Officer & CSO Inventor/innovator behind patented PolarityTE™ platform and derivatives MD/PhD from Georgetown University with Honors, Alpha Omega Alpha, Phi Beta Kappa > Johns Hopkins Plasticand Reconstructive Surgery Training Research Recipient of numerous resear

  7. Slide 7: The PolarityTEAM — Board of Directors

    The PolarityTEAM — Board of Directors Chairman & Chief Executive Officer | Edward (Ned) Swanson, MD ‘i Executive Vice President, COO, Director John Stetson Executive Vice President, CFO, Director a Management Steve Gorlin ¢ Director o 4 * Regenerative Medicine and Biotech Pioneer: . ‘4 Founder @hini

  8. Slide 8: The PolarityTEAM — Clinical Board of Advisors

    The PolarityTEAM — Clinical Board of Advisors es 4

  9. Slide 9: Global Regenerative Medicine and Wound Care Markets

    Global Regenerative Medicine and Wound Care Markets Current markets remain untapped with myopically-redundant and synthetic forms of tissue engineering Growth in Worldwide Prevalence of products which do not utilize the functional and inherently regenerative tissues of the patient. Wound Types, 2011

  10. Slide 10: SkinTE

  11. Slide 11: isM

    isM oe

  12. Slide 12: Current Therapies and their Fundamental Limitations

    urrent Therapies and their Fundamental Limitations No Cells: © Acellular scaffolds or matrices lack the innate ability to regenerate tissue and rely on surrounding tissue in-growth and ultimately secondary skin grafts for definitive coverage Allogeneic/Xenogeneic Cells: « Allogeneic (another person’

  13. Slide 13: Competitive Landscape

    Competitive Landscape A Massive Market Saturated with Stagnant Products Lacking Fundamental Principles and Building Blocks for True Functional Skin Regeneration Cellular Full Thickness Functional Product Company Cellular Cell Source Stem Cells Architecture and Skin Regeneration with Interfaces Appen

  14. Slide 14: The PolarityTE Platform Technology

    The PolarityTE™ Platform Technology Discovered through careful observation and the study of regenerative tissue healing and cellular propagation mechanisms in real-time, the PolarityTE™ Platform Technology has proved its regenerative capacity across a variety of tissue substrates and composite syste

  15. Slide 15: The PolarityTE Advantage — Complex Simplicity Made Real

    The PolarityTE™ Advantage — Complex Simplicity Made Real Autologous From the Patient for the Patient: The immune system is highly complex and has evolved to recognize anything that is not truly "self." Our foundational platform is built on using autologous tissue(s), avoiding allogeneic tissue rejec

  16. Slide 16: Development Pipeline of PolarityTE Construct COREs

    Development Pipeline of PolarityTE™ Construct COREs Preclinical Development Clinical Deployment Construct Ex Vivo Optimization Small Animal Large Animal Human Pilot Market Entry Sal 2H 2017 242017 $" Bo x > cipose Er > > 16.

  17. Slide 17: World's First: PolarityTE Develops Full-thickness Hair-Bearing Skin

    World's First: PolarityTE™ Develops Full-thickness Hair-Bearing Skin for Treatment of Burns, Wounds and Scars Deployment of SkinTE™ into Burns, Wounds and Scars Results in Progressive Regenerative Healing of Full-thickness Functionally-Polarized Skin

  18. Slide 18: Progression of Scarred Healing

    i, * Progression of Scarred Healing Progression of Regenerative Full-thickness Healing

  19. Slide 19: Progression of Regenerative Full-thickness Healing

    Progression of Regenerative Full-thickness Healing Native Skin Margin SkinTE™ *SkinTE not only regenerates full-thickness, organized skin within wound beds but will also propagates into old scar tissues and regenerates full-thickness skin (black arrows and dotted line)

  20. Slide 20: The PolarityTE Launch Platform Product—SkinTE

    The PolarityTE™ Launch Platform Product— SkinTE™ et Ieee gression of Scarred Healing 7) PolarityTE 20.

  21. Slide 21: Native Wound

    ‘Native Wound

  22. Slide 22: Comparison of the Clinical Gold Standard and SkinTE

    Comparison of the Clinical Gold Standard and SkinTE™ Native Scar Healed Wound Native Skin Allograft Margin —_Native Skin : . a — . = i Full-Thickness Allograft a «alll Autdgraft ]\\ Margin Native Skin Skin defects heal through a process of wound + contraction and often scar formation. While skin gra

  23. Slide 23: Wounds Heal from Margins—SkinTE Regenerates from Within

    Wounds Heal from Margins—SkinTE™ Regenerates from Within Mid-Stage Native Contracting Wound . SkinTE™ Mid-Stage Regenerative Wound wa ‘Contraction and Migration Epithelial Migration columns. ‘Mid-Stage SkinTE™ Integrative Convergence with Native Skin #48), Native Healed and Contracted Wound Pseudo-e

  24. Slide 24: It all begins and ends with a simple box

    It all begins and ends with a simple box

  25. Slide 25: The PolarityTE Harvest Box

    The PolarityTE™ Harvest Box — o 2).

  26. Slide 26: Box with Everything Needed Inside

    Ne Box with Everything Needed Inside

  27. Slide 27: Remove All System Contents

    Remove All System Contents ed nn cet j] <= rere 8 loa Excise Full-Thickness Skin Place in Specimen Container Load into PolarityTE™ Shipper 7) PolarityTE 27.

  28. Slide 28: Harvest System Provides Safety, Control and Communication

    Harvest System Provides Safety, Control and Communication Product Information ‘IN The PolarityTE™ Real-Time Assistant Allows 24-hour HIPAA-Compliant Support Including: Text, Email, Call, Face-to-Face Customer Service and Document Transfer with Polarity Physicians—Real Info in Real-Time between Real

  29. Slide 29: Who can be a Regenerative Medicine Provider with SkinTE?

    Who can be a Regenerative Medicine Provider with SkinTE™? Medical Physicians General and Subspecialty Surgeons RNs and PAs Harvest Skin™ Medical Responders and Medics enna Care Specialists KIN| E AK VINILT Standard Procedures, Processes and Care for Familiarity Boor 29.

  30. Slide 30: Easy Deployment of SkinTE at:

    Easy Deployment of SkinTE™ at: Office or Clinic Patient Bedside Outpatient Centers Operating Rooms Wound Care Centers The PolarityTE™ Deployment Box > 4 ee 30.

  31. Slide 31: Simple Deployment and Standard Basic Dressings with SkinTE

    Simple Deployment and Standard Basic Dressings with SkinTE™ Ngs iii wi 001 | wi 00 A sg oe *FOR AUTOLOGOUS USE ONIY* ‘ i 4 Ty nat ‘on yo N ,X 4) a TION A" et Ae _ Expiration Date: x/ioy/ 000 be If stored at +4°C Refrigeration ign 30

  32. Slide 32: Strategy, Pathway, and Timelines of Initial PolarityTE Products

    Strategy, Pathway, and Timelines of Initial PolarityTE™ Products Established cGMP/cGTP CLIA Manufacturing Product Registration & Market Entry Low Cost and Short Timeline to Revenue for Each Product FDA Product Registration of SkinTE™ Commercialization & Staged Market Entry Q3 2017 2H 2017 Large Anim

  33. Slide 33: The PolarityTE Product Pipeline is Primed and Polarized

    The PolarityTE™ Product Pipeline is Primed and Polarized

  34. Slide 34: Market Commercialization: National Landscape

    Market Commercia 2 National Landscape: 126 burn centers nationwide, creating a straightforward scale-up plan with SkinTE™ Market Introduction 2 Key Decision Makers: Burn Center treatments dictated by Burn Center Directors 2 Leaders in the Field on PolarityTE Team: Chief Clinical Officer Dr. Stephen

  35. Slide 35: Summary

    Summary PolarityTE™, Inc. (NASDAQ: COOL) The New Paradigm of Regenerative Medicine is Here And This Time it is Real with a Proven Platform Technology A Regenerative Medicine Company Like No Other A revolutionary and proprietary platform technology developing products to regenerate fully functional t

  36. Slide 36: PolarityTE — Welcome to the Shift

PolarityTE — Investor Presentation (September 2017) on 6ix